Abbott revenue misses as heart devices eclipse diabetes gains
October 16, 2019 at 12:18 PM EDT
Abbott Laboratories fell just short of Wall Street estimates for quarterly revenue on Wednesday, as weakness in the medical device maker's cardiovascular business overshadowed strong performance in its fast-growing diabetes care unit.
